Mostrar o registo simplificado do documento
Estrategia revisada de la OMS en materia de medicamentos: informe del Director General
dc.contributor.author | Asamblea Mundial de la Salud, 39 | |
dc.date.accessioned | 2015-12-04T17:19:16Z | |
dc.date.available | 2015-12-04T17:19:16Z | |
dc.date.issued | 1986 | |
dc.identifier.govdoc | A39/13 | |
dc.identifier.uri | https://iris.who.int/handle/10665/200414 | |
dc.description | (Punto 25 del orden del día provisional) | en_US |
dc.language.iso | es | en_US |
dc.publisher | Organización Mundial de la Salud | en_US |
dc.subject | Pharmaceutical products | en_US |
dc.subject.mesh | Pharmaceutical Preparations | en_US |
dc.subject.mesh | Drug Delivery Systems | en_US |
dc.subject.mesh | Drug Industry | en_US |
dc.subject.mesh | Drugs, Essential | en_US |
dc.title | Estrategia revisada de la OMS en materia de medicamentos: informe del Director General | en_US |
dc.type | Governing body documents | en_US |
dc.subject.meshqualifier | prevention and control | en_US |